# Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer

> **NCT06572735** · — · RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 50 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **OTHER:** QoL surveys
- **OTHER:** Geriatric assessment (G-CODE)
- **BIOLOGICAL:** Blood sampling

## Key facts

- **NCT ID:** NCT06572735
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-24
- **Primary completion:** 2028-01-23
- **Final completion:** 2028-01-23
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06572735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06572735, "Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06572735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*